Ara
Toplam kayıt 6, listelenen: 1-6
Long-term comparison of everolimus- vs. novolimus-eluting bioresorbable vascular scaffolds
(Elsevier Science Inc, 2020)
BACKGROUND The vast majority of clinical trials regarding bioresorbable vascular scaffold (BVS) use came from comparison of everolimus-eluting scaffolds with metallic stents, and it remains unclearwhether similar results ...
Angio-seal used as a bailout for incomplete hemostasis after dual perclose ProGlide deployment in transcatheter aortic valve implantation
(Texas Heart Institute, 2022)
Background: The failure rate of vascular closure devices remains a significant cause of major vascular complications in contemporary transcatheter aortic valve implantation practice. Methods: This research aimed to evaluate ...
Vascular complications after transcatheter transfemoral aortic valve implantation: Modified sheath-to-femoral artery ratio as a new predictor
(NLM (Medline), 2022)
OBJECTIVE: Vascular complications (VCs) contribute to increased morbidity and mortality in patients who have undergone transcatheter aortic valve implantation (TAVI); however, studies on their incidence and predictors show ...
Long-term outcomes of absorb bioresorbable vascular scaffold using predilation, sizing, and postdilation protocol in a real-world patient population
(NLM (Medline), 2021)
OBJECTIVE: Bioresorbable vascular scaffolds (BVSs) have been a disappointment in the evolution of drug-eluting stents used in percutaneous coronary intervention because an excessive number of thrombotic complications have ...
Long-term results of long segment coronary artery lesions overlapped with novolimus-eluting DESolve scaffold: Disappointment or futuristic?
(Turkish Society of Cardiology, 2021)
Objective: The data on using novolimus-eluting DESolve bioresorbable scaffolds (BVS) for long-segment coronary artery lesions remains insufficient. In this study, our main objective was to assess the long-term effects of ...
How accurate are manufacturers' recommendations in determining ineligibility for transfemoral transcatheter aortic valve implantation?
(Sociedade Portuguesa De Cardiologia, 2023)
Introduction: Up to one-third of patients indicated for transcatheter aortic valve implantation (TAVI) may be unsuitable for transfemoral TAVI (TF-TAVI) according to manufacturers' recommendations and numerous professional ...